GELS · Gelteq Ltd
United States · RS rating 27 · As of 2026-11-03
| Price | 0.49 USD |
|---|---|
| 1-day change | -0.2% |
| RS rating (overall / 1M / 3M / 12M) | 27 / 35 / 40 / 17 |
| Stage | Declining |
| Composite / Minervini / CANSLIM score | 18 / 12 / 4 |
| Industry group (rank) | Medical-Generic Drugs (136) |
| EPS growth Q/Q | – |
| Sales growth Q/Q | – |
| Distance from 52-week high | +68.0% |
| Market cap (USD) | $7.2M |